Personal tools

Coexpression cluster:C1875

From FANTOM5_SSTAR

Revision as of 17:44, 8 August 2012 by Autoedit (talk | contribs)
Jump to: navigation, search


Full id: C1875_migratory_CD14_CD14CD16_CD4_Basophils_NK_acute



Phase1 CAGE Peaks

Hg19::chr21:15918672..15918683,-p2@SAMSN1
Hg19::chr3:84892515..84892517,+p@chr3:84892515..84892517
+
Hg19::chr7:45016548..45016567,-p5@MYO1G
Hg19::chr7:45018571..45018589,-p3@MYO1G
Hg19::chr7:45018602..45018625,-p1@MYO1G


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0001784phosphotyrosine binding0.00459167901859403
GO:0045309protein phosphorylated amino acid binding0.00459167901859403
GO:0051219phosphoprotein binding0.00510156518817511
GO:0016459myosin complex0.0408816032450061



Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>


Cell Type
Ontology termp-valuen
hematopoietic stem cell2.14e-89172
angioblastic mesenchymal cell2.14e-89172
hematopoietic oligopotent progenitor cell1.75e-85165
hematopoietic multipotent progenitor cell1.75e-85165
hematopoietic cell3.98e-84182
leukocyte5.22e-74140
hematopoietic lineage restricted progenitor cell2.17e-62124
nongranular leukocyte1.85e-61119
myeloid cell1.37e-55112
common myeloid progenitor1.37e-55112
myeloid leukocyte1.98e-3976
granulocyte monocyte progenitor cell3.91e-3671
myeloid lineage restricted progenitor cell1.31e-3470
macrophage dendritic cell progenitor4.19e-3465
monopoietic cell6.02e-3363
monocyte6.02e-3363
monoblast6.02e-3363
promonocyte6.02e-3363
classical monocyte3.00e-3245
CD14-positive, CD16-negative classical monocyte1.64e-3142
lymphocyte1.56e-2453
common lymphoid progenitor1.56e-2453
lymphoid lineage restricted progenitor cell3.09e-2452
T cell5.73e-1425
pro-T cell5.73e-1425
mesenchymal cell1.59e-13358
connective tissue cell2.23e-12365
mature alpha-beta T cell9.52e-1118
alpha-beta T cell9.52e-1118
immature T cell9.52e-1118
mature T cell9.52e-1118
immature alpha-beta T cell9.52e-1118
lymphocyte of B lineage4.14e-1024
pro-B cell4.14e-1024
motile cell1.02e-08390
intermediate monocyte2.03e-079
CD14-positive, CD16-positive monocyte2.03e-079
CD8-positive, alpha-beta T cell3.92e-0711
Uber Anatomy
Ontology termp-valuen
hematopoietic system1.18e-41102
blood island1.18e-41102
hemolymphoid system1.26e-36112
bone marrow3.16e-3080
bone element1.19e-2586
immune system7.52e-22115
skeletal element4.08e-18101
skeletal system4.08e-18101
adult organism6.70e-14115
connective tissue4.40e-11375
lateral plate mesoderm6.41e-11216
blood1.10e-0815
haemolymphatic fluid1.10e-0815
organism substance1.10e-0815
Disease
Ontology termp-valuen
hematologic cancer5.79e-1751
immune system cancer5.79e-1751
leukemia5.65e-1539
myeloid leukemia3.67e-1231


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.